Abstract
Background: Real time reverse transcription polymerase chain reaction (real time RT-PCR) testing is the gold standard for the diagnosis of SARS-CoV-2 infections. However, to expand the testing capacity, new SARS-CoV-2 rapid antigen tests (Ag-RDTs) have been implemented. Ag-RDTs are more rapid, but less reliable in terms of sensitivity, and real-life data on their performance in comparison with the real time RT-PCR test are lacking.
Methods: We aimed at assessing the diagnostic performance of the third-generation antigenic swab LumiraDx™ compared with real time RT-PCR in a retrospective cohort study at the Infectious Diseases Unit of Padua. All of the patients who were consecutively tested for SARS-CoV-2 in our centre (by both real time RT-PCR and Ag-RTD LumiraDx TM ) from 19 January to 30 May 2021, were included. Cycle-threshold (Ct) values of positive real time RT-PCR were recorded as well as the number of days from symptoms’ onset to testing.
Results: Among the 282 patients included, 80.9% (N = 228) tested positive to real time RT-PCR, and among these, 174 tested positive also to LumiraDx™. Compared with real time RT-PCR, which is considered as the gold standard for the assessment of the presence/absence of SARS-CoV-2 infection, LumiraDx™ showed an overall sensitivity of 76.3% and specificity of 94.4%. Sensitivity increased to 91% when testing was performed <10 days from symptoms’ onset, and to 95% when considering Ct < 25. Multivariable binomial logistic regression showed that false negative LumiraDx™ results were significantly associated with high Ct values, and with further testing from symptoms’ onset.
Conclusions: The results of our study suggested that the LumiraDx™ SARS-CoV-2 antigen assay may be appropriate for the detection of SARS-CoV-2 infection, especially in its early phase when the test largely meets the performance requirements of the European Centre for Disease Prevention and Control (ECDC).
Keywords: COVID-19; RT-PCR; SARS-CoV-2; accuracy; agreement; diagnosis; negative predictive value; positive predictive value; rapid antigen testing; sensitivity; specificity.
【저자키워드】 COVID-19, SARS-CoV-2, Diagnosis, RT-PCR, sensitivity, Positive predictive value, Accuracy, rapid antigen testing, agreement, specificity., Negative predictive value, 【초록키워드】 SARS-COV-2 infection, diagnostic, prevention, Symptom, Infectious disease, RT-PCR, Predictive value, Antigen, reverse transcription polymerase chain reaction, polymerase chain reaction, specificity, Rapid antigen tests, infections, Positive predictive value, rapid antigen test, Patient, Control, Logistic regression, gold, reverse transcription, Swab, SARS-CoV-2 antigen, Ag-RDT, SARS-CoV-2 infections, False negative, Prevention and control, RT-PCR test, real time, RDTs, Negative predictive value, Predictive, Chain Reaction, retrospective cohort study, gold standard, early phase, antigenic, Real time reverse transcription polymerase chain reaction, Ag-RDTs, unit, positive, ECDC, European, new SARS-CoV-2, polymerase chain, tested, significantly, the patient, was performed, less, suggested, expand, were recorded, diagnosis of SARS-CoV-2, meet, 【제목키워드】 Test, Rapid, reaction, chain, time,